Extragastric manifestations of Helicobacter pylori infection

Marko Banić1, Francesco Franceschi, Zarko Babić

  • 1Division of Gastroenterology, University Hospital Dubrava, Zagreb, Croatia.

Helicobacter
|September 11, 2012
PubMed

Insights

Helicobacter pylori infection is increasingly linked to diseases beyond the stomach, including cardiovascular and hematologic disorders. Research is rapidly expanding, with numerous studies exploring these extra-gastric conditions.

Area of Science:

  • Microbiology
  • Internal Medicine
  • Epidemiology

Background:

  • Helicobacter pylori (H. pylori) is a bacterium primarily known for causing gastric diseases.
  • Emerging evidence suggests H. pylori may be implicated in conditions outside the gastrointestinal tract.
  • Recent research has focused on the potential role of H. pylori in various systemic diseases.

Purpose of the Study:

  • To review and summarize recent investigations into diseases potentially linked to H. pylori infection outside the stomach.
  • To highlight the growing body of research exploring extra-gastric manifestations of H. pylori.
  • To underscore the global research interest in this expanding field.

Main Methods:

  • Literature review of studies published within the last year.
  • Analysis of research concerning cardiovascular, hematologic, neurologic, metabolic, and hepatobiliary diseases.
  • Inclusion of studies ranging from large-scale investigations to case reports.

Main Results:

  • Multiple studies have explored links between H. pylori and conditions such as sideropenic anemia and idiopathic thrombocytopenic purpura.
  • Research indicates potential associations with cardiovascular, neurologic, metabolic, and hepatobiliary diseases.
  • The scope of investigated conditions linked to H. pylori has significantly broadened.

Conclusions:

  • H. pylori infection is being investigated for its potential role in a diverse range of extra-gastric diseases.
  • The breadth and depth of research indicate a significant and growing interest in H. pylori's systemic effects.
  • Further investigation is warranted to elucidate the mechanisms and clinical significance of these associations.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...